ID Name Structure References (top 5) Molecular Target(s)
1ID:177
AKEBOSIDE STJ

Freqency:
in 1 ingredients:

  • 44
  • in 8 recipes:

  • 236
  • 274
  • 285
  • 289
  • 324
  • 337
  • 405
  • 409

  • Properties
    C65H106O30    1367.52





    1:  Hodsman AB, Kisiel M, Adachi JD, Fraher LJ, Watson PH.
    Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis.
    Bone.    impact factor:   3.961
    2000;  27(2): 311-8

    2:  Hodsman AB, Watson PH, Drost D, Holdsworth D, Thornton M, Hock J, Bryant H, Fraher LJ.
    Assessment of maintenance therapy with reduced doses of PTH(1-34) in combination with a raloxifene analogue (LY117018) following anabolic therapy in the ovariectomized rat.
    Bone.    impact factor:   3.961
    1999;  24(5): 451-5

    3:  Vilos GA.
    Intrauterine surgery using a new coaxial bipolar electrode in normal saline solution (Versapoint): a pilot study.
    Fertil Steril.    impact factor:   2.955
    1999;  72(4): 740-3

    4:  Lim K, Dieppe P.
    Osteoarthritis of the scapho-trapezial joint.
    Br J Rheumatol.    impact factor:   2.845
    1994;  33(12): 1142-4

    5:  Westmacott G, Zhong F, Frank M, Friedrich S, Labov SE, Benner WH.
    Investigating ion-surface collisions with a niobium superconducting tunnel junction detector in a time-of-flight mass spectrometer
    Rapid Commun Mass Spectrom.    impact factor:   2.184
    2000;  14(7): 600-7

     
    Time used: 172 milliseconds.

    Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005